Associate Professor, Medicine-Massachusetts General Hospital, Harvard Medical School
Endocrinology
Dr. Benjamin Z. Leder, MD
Benjamin Leder is an expert in the field of Endocrinology. He researched medicine at Harvard Medical School. Harvard Medical School is one of the top medical schools in the US. Harvard Medical School is ranked 1 in research and 12 in primary care medicine He received awards:"Regional Top Doctor", "Meaningful Use Stage 1 Certification" and "Elected Member". Dr. Benjamin Z. Leder is a published MD. He has 44 papers published. The most current publication "Effects of Two Years of Teriparatide, Denosumab, or Both on Bone Microarchitecture and Strength (DATA-HRpQCT study)." He accepts all Medicare patients.
Publications
- Response to Therapy With Teriparatide, Denosumab, or Both in Postmenopausal Women in the DATA (Denosumab and Teriparatide Administration) Study Randomized Controlled T...
- Comparative effects of teriparatide, denosumab, and combination therapy on peripheral compartmental bone density, microarchitecture, and estimated strength: the DATA-H...
- Effects of Abaloparatide, a Human Parathyroid Hormone-related Peptide Analog, on Bone Mineral Density in Postmenopausal Women with Osteoporosis.
- Effects of Escitalopram on Markers of Bone Turnover: a Randomized Clinical Trial.
- FSH Suppression Does Not Affect Bone Turnover in Eugonadal Men.
- Two Years of Denosumab and Teriparatide Administration in Postmenopausal Women with Osteoporosis (The DATA Extension Study): a Randomized Controlled Trial.
- Teriparatide (PTH 1-34) Treatment Increases Peripheral Hematopoietic Stem Cells in Postmenopausal Women.
- Gonadal steroids and body composition, strength, and sexual function in men.
- Teriparatide and denosumab, alone or combined, in women with postmenopausal Osteoporosis: the DATA study randomised trial.
- Anabolic therapies for Osteoporosis.
- Sarcopenia During Androgen-Deprivation Therapy for Prostate Cancer.
- Bisphosphonates for Osteoporosis: benefits and risks.
- Acute Decline in Serum Sclerostin in Response to PTH Infusion in Healthy Men.
- Denosumab and changes in bone turnover markers during androgen deprivation therapy for prostate cancer.
- Effects of aromatase inhibition on bone mineral density and bone turnover in older men with low testosterone levels.
- Effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancer.
- Effects of hPTH(1-34) infusion on circulating serum phosphate, 1,25-dihydroxyVitamin D, and FGF23 levels in healthy men.
- Effects of teriparatide treatment and discontinuation in postmenopausal women and eugonadal men with Osteoporosis.
- Effects of teriparatide retreatment in osteoporotic men and women.
- Relation between serum testosterone, serum estradiol, sex hormone-binding globulin, and geometrical measures of adult male proximal femur strength.
- Effects of aromatase inhibition in hypogonadal older men: a randomized, double-blind, placebo-controlled trial.
- Correlations between serum testosterone, estradiol, and sex hormone-binding globulin and bone mineral density in a diverse sample of men.
- Racial and ethnic differences in bone turnover markers in men.
- Effects of gonadal steroid withdrawal on serum phosphate and FGF-23 levels in men.
- Effects of teriparatide, alendronate, or both on bone turnover in osteoporotic men.
- Effects of selective testosterone and estradiol withdrawal on skeletal sensitivity to parathyroid hormone in men.
- Effects of aromatase inhibition in elderly men with low or borderline-low serum testosterone levels.
- Differential effects of androgens and estrogens on bone turnover in normal men.
- Effects of oral androstenedione administration on serum testosterone and estradiol levels in postmenopausal women.
- Effects of androstenedione administration on epitestosterone Metabolism in men.
- Testosterone, estradiol and aromatase inhibitor therapy in elderly men.
- Is parathyroid hormone (1-84) a safe and effective treatment for postmenopausal Osteoporosis?
- Gonadal steroids and bone Metabolism in men.
- Patient information page from the Hormone Foundation. High blood Calcium (Hypercalcemia).
- Denosumab in men receiving androgen-deprivation therapy for prostate cancer.
- Effect of aromatase inhibition on Lipids and inflammatory markers of cardiovascular disease in elderly men with low testosterone levels.
- Effect of aromatase inhibition on bone Metabolism in elderly hypogonadal men.
- Oral androstenedione administration and serum testosterone concentrations in young men.
- Gastroenterologists and choosing the right bisphosphonate.
- Trace contamination of over-the-counter androstenedione and positive urine test results for a nandrolone metabolite.
- Effects of gonadal steroid suppression on skeletal sensitivity to parathyroid hormone in men.
- Metabolism of orally administered androstenedione in young men.
- Effects of Two Years of Teriparatide, Denosumab, or Both on Bone Microarchitecture and Strength (DATA-HRpQCT study).
Schools
Harvard Medical School
Massachusetts General Hospital
Conditions Treated
- Adrenal Insufficiency
- Calcium Metabolism Disorders
- Goiter
- Hyperkalemia
- View All
Doctors Specialties
Accepted Insurances
Awards
- Regional Top Doctor
- Meaningful Use Stage 1 Certification
- Elected Member
Education
-
Massachusetts General Hospital
-
Harvard Medical School
Hospital
-
Massachusetts General Hospital
Drug Facts
| NPI NUMBER |
|
1982783924 |
| NPPES Provider LastName |
|
LEDER |
| NPPES Provider FirstName |
|
BENJAMIN |
| NPPES Provider ZIPCode |
|
021143117 |
| NPPES Provider State |
|
MA |
| Specialty Description |
|
Endocrinology |
| Total Claim Count |
|
95.0 |
| Distinct Opioid Count |
|
0.0 |
| Opioid Claim Count |
|
0.0 |
| Percent Opioid Claims |
|
0.0 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
| National Provider Identifier [NPI] |
1982783924 |
| Last Name Of The Provider |
LEDER |
| First Name Of The Provider |
BENJAMIN |
| View All |
|
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog
This Doctor is OpenDoctor Recommended.
This doctor has more publications